Literature DB >> 32152245

Systems Biological Analysis of Immune Response to Influenza Vaccination.

Mario Cortese1, Amy C Sherman2, Nadine G Rouphael2, Bali Pulendran1,3,3.   

Abstract

The last decade has witnessed tremendous progress in immunology and vaccinology, owing to several scientific and technological breakthroughs. Systems vaccinology is a field that has emerged at the forefront of vaccine research and development and provides a unique way to probe immune responses to vaccination in humans. The goals of systems vaccinology are to use systems-based approaches to define signatures that can be used to predict vaccine immunogenicity and efficacy and to delineate the molecular mechanisms driving protective immunity. The application of systems biological approaches in influenza vaccination studies has enabled the discovery of early signatures that predict immunogenicity to vaccination and yielded novel mechanistic insights about vaccine-induced immunity. Here we review the contributions of systems vaccinology to influenza vaccine development and critically examine the potential of systems vaccinology toward enabling the development of a universal influenza vaccine that provides robust and durable immunity against diverse influenza viruses.
Copyright © 2021 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32152245      PMCID: PMC7483643          DOI: 10.1101/cshperspect.a038596

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   5.159


  6 in total

Review 1.  Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?

Authors:  P J Klasse; Gabriel Ozorowski; Rogier W Sanders; John P Moore
Journal:  Cell Host Microbe       Date:  2020-04-08       Impact factor: 21.023

Review 2.  Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change.

Authors:  Tamas Fulop; Anis Larbi; Graham Pawelec; Alan A Cohen; Guillaume Provost; Abedelouahed Khalil; Guy Lacombe; Serafim Rodrigues; Mathieu Desroches; Katsuiku Hirokawa; Claudio Franceschi; Jacek M Witkowski
Journal:  Vaccines (Basel)       Date:  2022-04-13

Review 3.  The immunology of SARS-CoV-2 infections and vaccines.

Authors:  Lilit Grigoryan; Bali Pulendran
Journal:  Semin Immunol       Date:  2020-11-17       Impact factor: 11.130

4.  The effect of influenza vaccine in reducing the severity of clinical outcomes in patients with COVID-19: a systematic review and meta-analysis.

Authors:  Hossam Waleed Almadhoon; Aboalmagd Hamdallah; Sarah Makram Elsayed; Abdulrahman Ibrahim Hagrass; Mohammed Tarek Hasan; Aya Mamdouh Fayoud; Mohammed Al-Kafarna; Mohammad Elbahnasawy; Fadel Alqatati; Khaled Mohamed Ragab; Mohamed Sayed Zaazouee; Elfatih A Hasabo
Journal:  Sci Rep       Date:  2022-08-22       Impact factor: 4.996

Review 5.  The role of cell-mediated immunity against influenza and its implications for vaccine evaluation.

Authors:  Yorick Janssens; Jasper Joye; Gwenn Waerlop; Frédéric Clement; Geert Leroux-Roels; Isabel Leroux-Roels
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

Review 6.  The Status and Prospects of Epstein-Barr Virus Prophylactic Vaccine Development.

Authors:  Cong Sun; Xin-Chun Chen; Yin-Feng Kang; Mu-Sheng Zeng
Journal:  Front Immunol       Date:  2021-06-08       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.